Asia Pacific Dermatology Diagnostic Devices Market Research Report - Segmented By Type, Application, Dermatoscopes & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts 2024 to 2029

Updated On: January, 2024
ID: 5034
Pages: 145

APAC Dermatology Diagnostic Devices Market Size & Growth (2022 to 2027):

As per the research report, the size of the Asia Pacific Dermatology Diagnostic Devices market was valued at USD 5.28 billion in 2022. It is expected to grow at a CAGR of 7.8% to reach USD 7.69 billion by 2027 during the forecast period 2022 to 2027. It captures 20% of the global market.

Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding aesthetics. This has led to rising awareness about various types of aesthetic procedures used for treating hair- and skin-related disorders. Primarily, women suffer from these disorders. Therefore, they are the highest revenue makers in the market.

Increasing the incidence of skin disorders, growing awareness regarding aesthetic procedures, technological advancements, and rising healthcare expenditure are the primary drivers of the market.

This research report on the APAC Dermatology Diagnostic Devices Market has been segmented and sub-segmented into the following categories:

By Type:

  • Dermatoscopes
  • Microscopes
  • Imaging Devices

By Application:

  • Skin Cancer Diagnosis
  • Other Diagnostic Applications

By Dermatoscopes:

  • Contact Oil Immersion Dermatoscopes
  • Cross-Polarized Dermatoscopes
  • Hybrid Dermatoscopes      

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The imaging devices category is anticipated to command the largest share of the market during the aforementioned forecast period. It is due to the technological advancements and rising awareness regarding aesthetic procedures. The skin cancer diagnosis segment is expected to account for the largest share of the market during the forecast period.

It is the third-largest market. Asia is anticipated to experience the highest CAGR during the aforementioned forecast period, with the development in this market centered on Japan, China, and India. Increasing the incidence of skin diseases, rising healthcare expenditure, and growing awareness regarding aesthetic procedures are the reasons attributable to the observable trend mentioned above.

The Top companies leading in the APAC Dermatology Diagnostic Devices Market profiled in the report are 3Gen Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Valeant Pharmaceuticals (Canada), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.).

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample